Neurocrine Biosciences, Inc.’s recent filing unveils that its Chief Commercial Officer BENEVICH ERIC unloaded Company’s shares for reported $2.64 million on Apr 15 ’24. In the deal valued at $133.36 per share,19,818 shares were sold. As a result of this transaction, BENEVICH ERIC now holds 40,778 shares worth roughly $5.45 million.
Then, Delaet Ingrid sold 272 shares, generating $37,346 in total proceeds. Upon selling the shares at $137.30, the Chief Regulatory Officer now owns 7,507 shares.
Before that, Delaet Ingrid sold 5,000 shares. Neurocrine Biosciences, Inc. shares valued at $725,320 were divested by the Chief Regulatory Officer at a price of $145.06 per share. As a result of the transaction, Delaet Ingrid now holds 7,507 shares, worth roughly $1.0 million.
A number of analysts have revised their coverage, including Deutsche Bank’s analysts, who began to cover the stock in mid December with a ‘”a Buy”‘ rating. Mizuho maintained its rating on August 21, 2023. It rated NBIX as “a Neutral”.
Price Performance Review of NBIX
On Monday, Neurocrine Biosciences, Inc. [NASDAQ:NBIX] saw its stock jump 1.26% to $133.66. Over the last five days, the stock has gained 1.46%. Neurocrine Biosciences, Inc. shares have risen nearly 1.44% since the year began. Nevertheless, the stocks have risen 27.83% over the past one year. While a 52-week high of $148.37 was reached on 03/21/24, a 52-week low of $89.04 was recorded on 02/07/24. SMA at 50 days reached $136.06, while 200 days put it at $120.55. A total of 0.58 million shares were traded, compared to the trading of 0.59 million shares in the previous session.
Levels Of Support And Resistance For NBIX Stock
The 24-hour chart illustrates a support level at 132.24, which if violated will result in even more drops to 130.83. On the upside, there is a resistance level at 134.63. A further resistance level may holdings at 135.60. The Relative Strength Index (RSI) on the 14-day chart is 43.31, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -2.79, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 68.82%. Stochastics %K at 20.68% indicates the stock is a holding.
